UGT1A1 is a major locus influencing bilirubin levels in African Americans

European Journal of Human Genetics

Volumn 20, Issue 4, 2012, Pages 463-468

  Chen, Guanjie ^a   Ramos, Edward ^a   Adeyemo, Adebowale ^a   Shriner, Daniel ^a   Zhou, Jie ^a   Doumatey, Ayo P ^a   Huang, Hanxia ^a   Erdos, Michael R ^a   Gerry, Norman P ^b   Herbert, Alan ^c   Bentley, Amy R ^a   Xu, Huichun ^a   Charles, Bashira A ^a   Christman, Michael F ^b   Rotimi, Charles N ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b Laboratory of Molecular and Cellular Biology of Hematopoiesis   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

African Americans; bilirubin; GWAS; replications

Indexed keywords

BILIRUBIN; DNA; GLYCOSYLTRANSFERASE; PHENOBARBITAL; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1;

ADULT; AFRICAN AMERICAN; ARTICLE; BILIRUBIN BLOOD LEVEL; FAMILY STUDY; FEMALE; GENETIC ANALYSIS; GENETIC MODEL; GENOME ANALYSIS; GENOTYPE; HUMAN; HYPERBILIRUBINEMIA; MAJOR CLINICAL STUDY; MALE; POPULATION GENETICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AFRICAN AMERICANS; BILIRUBIN; FEMALE; GLUCURONOSYLTRANSFERASE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED;

EID: 84858337105     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2011.206     Document Type: Article

References (35)

1. Arias IM: The excretion of conjugated bilirubin by the liver cell. Medicine (Baltimore) 1966; 45: 513-515.
2. McDonagh AF: Bilirubin toxicity to human erythrocytes: A more sanguine view. Pediatrics 2007; 120: 175-178.
3. Ritter JK, Crawford JM, Owens IS: Cloning of two human liver bilirubin UDP-glucuronosyltransferase cDNAs with expression in COS-1 cells. J Biol Chem1991; 266: 1043-1047.
4. Pacheco PR, Brilhante MJ, Ballart C et al: UGT1A1, UGT1A6 and UGT1A7 genetic analysis: Repercussion for irinotecan pharmacogenetics in the Sao Miguel Island Population (Azores, Portugal). Mol Diagn Ther 2009; 13: 261-268.
5. Hunt SC, Kronenberg F, Eckfeldt JH, Hopkins PN, Myers RH, Heiss G: Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: The NHLBI family heart study. Atherosclerosis 2001; 154: 747-754.
6. Schwertner HA, Jackson WG, Tolan G: Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem 1994; 40: 18-23.
7. Breimer LH, Wannamethee G, Ebrahim S, Shaper AG: Serum bilirubin and risk of ischemic heart disease in middle-aged British men. Clin Chem 1995; 41: 1504-1508.
8. Lin JP, Vitek L, Schwertner HA: Serum bilirubin and genes controlling bilirubin concentrations as biomarkers for cardiovascular disease. Clin Chem 2010; 56: 1535-1543.
9. Han SS, Na KY, Chae DW, Kim YS, Kim S, Chin HJ: High serum bilirubin is associated with the reduced risk of diabetes mellitus and diabetic nephropathy. Tohoku J ExpMed 2010; 221: 133-140.
10. Horsfall LJ, Rait G, Walters K et al: Serum bilirubin and risk of respiratory disease and death. Jama 2011; 305: 691-697.
11. Han SS, Na KY, Chae DW, Kim YS, Kim S, Chin HJ: Survival benefit of high serum bilirubin and low alkaline phosphatase in older adults. J Am Geriatr Soc 2010; 58: 1413-1415.
12. Melton PE, Haack K, Goring HH et al: Genetic influences on serum bilirubin in American Indians: The Strong Heart Family Study. Am J Hum Biol 2011; 23: 118-125.
13. Lin JP, Schwaiger JP, Cupples LA et al: Conditional linkage and genome-wide association studies identify UGT1A1 as a major gene for anti-atherogenic serum bilirubin levels - the Framingham Heart Study. Atherosclerosis 2009; 206: 228-233.
14. Kronenberg F, Coon H, Gutin A et al: A genome scan for loci influencing antiatherogenic serum bilirubin levels. Eur J Hum Genet 2002; 10: 539-546.
15. Kang TW, Kim HJ, Ju H et al: Genome-wide association of serum bilirubin levels in Korean population. Hum Mol Genet 2010; 19: 3672-3678.
16. Johnson AD, Kavousi M, Smith AV et al: Genome-wide association meta-analysis for total serum bilirubin levels. Hum Mol Genet 2009; 18: 2700-2710.
17. Sanna S, Busonero F, Maschio A et al: Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia. Hum Mol Genet 2009; 18: 2711-2718.
18. Manolio TA, Burke GL, Savage PJ et al: Sex- and race-related differences in liverassociated serum chemistry tests in young adults in the CARDIA study. Clin Chem 1992; 38: 1853-1859.
19. Horsfall LJ, Zeitlyn D, Tarekegn A et al: Prevalence of clinically relevant UGT1A alleles and haplotypes in African populations. Ann Hum Genet 2011; 75: 236-246.
20. Adeyemo A, Gerry N, Chen G et al: A genome-wide association study of hypertension and blood pressure in African Americans. PLoS Genet 2009; 5: E1000564.
21. Almasy L, Blangero J: Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998; 62: 1198-1211.
22. McCarroll SA, Kuruvilla FG, Korn JM et al: Integrated detection and population-genetic analysis of SNPs and copy number variation. Nat Genet 2008; 40: 1166-1174.
23. Shriner D, Adeyemo A, Gerry NP et al: Transferability and fine-mapping of genome-wide associated loci for adult height across human populations. PLoS One 2009; 4: E8398.
24. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D: Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38: 904-909.
25. Purcell S, Neale B, Todd-Brown K et al: PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575.
26. Devlin B, Roeder K: Genomic control for association studies. Biometrics 1999; 55: 997-1004.
27. Ramos E, Chen G, Shriner D et al: Replication of genome-wide association studies (GWAS) loci for fasting plasma glucose in African-Americans. Diabetologia 2011; 54: 783-788.
28. Bretherton CS WM, Dymnikov VP, Wallace JM, Blade I: The effective number of spatial degrees of freedom of a time-varying field. J Climate 1999; 12: 1990-2009.
29. Gauderman WJ: Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol 2002; 155: 478-484.
30. Zucker SD, Horn PS, Sherman KE: Serum bilirubin levels in the U.S. population: Gender effect and inverse correlation with colorectal cancer. Hepatology 2004; 40: 827-835.
31. van Es HH, Bout A, Liu J et al: Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. Cytogenet Cell Genet 1993; 63: 114-116.
32. Charles BA, Shriner D, Doumatey A et al: A genome-wide association study of serum uric acid in African Americans. BMC Med Genomics 2011; 4: 17.
33. Innocenti F, Kroetz DL, Schuetz E et al: Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics. J Clin Oncol 2009; 27: 2604-2614.
34. Beutler E, Gelbart T, Demina A: Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: A balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci U S A 1998; 95: 8170-8174.
35. Bertola A, Bonnafous S, Anty R et al: Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients. PLoS One 2010; 5: E13577.